CEBPB and chronic myelogenous leukemia, BCR-ABL1 positive: Therefore, blocking BCR-ABL1, or its downstream C/EBPβ, TGF-β and arginase with inhibitors or shRNAs rescued T cell suppression by neutrophil-like CML cells.